Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Klaria Pharma Holding AB (KLAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8168
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Klaria Pharma Holding AB (Klaria Pharma) is a developer of fast acting medicinal products that designes, develops and commercializ therapeutics for migraine and cancer related pain. The company’s patented drug delivery platform is an alginate-based polymer film, facilitates quick and dependable transmucosal absorption of clinically established and marketed substances. It also offers reliable and stable supply forms than tablets and other delivery systems such as nasal sprays and orally dissolvable tablets. Klaria Pharma offers its products to customers globally through distributors. The company works in partnership with local pharmaceutical companies on clinical trials, registration, marketing, manufacturing, and others. Klaria Pharma is headquartered in Uppsala, Sweden.

Klaria Pharma Holding AB (KLAR) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Klaria Pharma Partners with Recipharm and Clinical Trial Consultants 10
Licensing Agreements 11
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 11
Klaria Pharma Enters into Licensing Agreement with Uppsalagruppen Medical 12
Equity Offering 13
Klaria Pharma Raises USD5.8 Million in Public Offering of Shares 13
Acquisition 14
Klaria Pharma Acquires Klaria AB for USD15.2 Million 14
Klaria Pharma Holding AB – Key Competitors 15
Klaria Pharma Holding AB – Key Employees 16
Klaria Pharma Holding AB – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klaria Pharma Holding AB, Deals By Therapy Area, 2012 to YTD 2018 8
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Klaria Pharma Partners with Recipharm and Clinical Trial Consultants 10
Purdue Pharma Canada Enters into Licensing Agreement with Klaria Pharma 11
Klaria Pharma Enters into Licensing Agreement with Uppsalagruppen Medical 12
Klaria Pharma Raises USD5.8 Million in Public Offering of Shares 13
Klaria Pharma Acquires Klaria AB for USD15.2 Million 14
Klaria Pharma Holding AB, Key Competitors 15
Klaria Pharma Holding AB, Key Employees 16
Klaria Pharma Holding AB, Subsidiaries 17

List of Figures
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Klaria Pharma Holding AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Klaria Pharma Holding AB (KLAR):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ethicon US LLC:企業の戦略的SWOT分析
    Ethicon US LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • PT Bukit Uluwatu Villa Tbk:企業の戦略・SWOT・財務情報
    PT Bukit Uluwatu Villa Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bukit Uluwatu Villa Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Seven & i Holdings Co., Ltd.:企業の戦略・SWOT・財務分析
    Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven & i Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Chico’s FAS Inc:戦略・SWOT・企業財務分析
    Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report Summary Chico's FAS Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • VTT Technical Research Centre of Finland-製薬・医療分野:企業M&A・提携分析
    Summary VTT Technical Research Centre of Finland (VTT) is a research and technology center that offers development services. The center provides research services on bioeconomy and circular economy, health and wellbeing, digital society, low carbon energy, smart industry, sustainable and smart city, …
  • Corindus Vascular Robotics Inc (CVRS):企業の財務・戦略的SWOT分析
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • Companhia de Saneamento Basico do Estado de Sao Paulo (SBSP3):企業の財務・戦略的SWOT分析
    Summary Companhia de Saneamento Basico do Estado de Sao Paulo (SABESP) is an environmental consulting company that is responsible for supplying water and collecting and treating sewage in municipalities of Sao Paulo state. The company provides water and sewage services in another four municipalities …
  • Banco do Nordeste SA:企業の戦略・SWOT・財務分析
    Banco do Nordeste SA - Strategy, SWOT and Corporate Finance Report Summary Banco do Nordeste SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • National Life & General Insurance Company SAOC (NLIF):企業の財務・戦略的SWOT分析
    National Life & General Insurance Company SAOC (NLIF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s …
  • San Leon Energy Plc (SLE):企業の財務・戦略的SWOT分析
    Summary San Leon Energy Plc (San Leon) is an oil and gas exploration and production company. It is engaged in acquiring, exploring and developing conventional and shale oil and gas assets across Europe and North Africa. The company holds interests in Durresi Block located in offshore Albania and inc …
  • Electricity Generating Public Co Ltd (EGCO):電力:M&Aディール及び事業提携情報
    Summary Electricity Generating Public Co Ltd (EGCO), a subsidiary of Electricity Generating Authority of Thailand (EGAT), is an energy utility. It produces electricity from natural gas, coal, biomass, waste, hydro, solar, wind, and geothermal sources. Through interests in independent power producer …
  • Oscotec Inc (039200):企業の財務・戦略的SWOT分析
    Summary Oscotec Inc (Oscotec) is a biotechnology company which discovers and develops drugs for cancer treatments. The company’s pipeline products include SKI-O-703, a spleen tyrosine kinase (SYK) inhibitor, against rheumatoid arthritis and idiopathic thrombocytopenic purpura; lazertinib (GNS-1480 Y …
  • AFGlobal Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary AFGlobal Corp (AFGlobal), formerly Ameriforge Group Inc is an engineering service provider that offers manufacturing, technology and precision engineering services. The company's services comprise forging, welding, machining, heat treat, fabrication and assembly, and testing and inspection. …
  • TAG Oil Ltd (TAO):企業の財務・戦略的SWOT分析
    Summary TAG Oil Ltd (TAG Oil) is an oil and gas exploration company engaged in the production of crude oil and natural gas across Canada. The company owns and operates oil and gas properties in Surat Basin and Taranaki Basin. The Taranaki Basin is located to the North Island of New Zealand. The comp …
  • DURECT Corp (DRRX):医療機器:M&Aディール及び事業提携情報
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Mitochon Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mitochon Pharmaceuticals Inc (Mitochon Pharma) is a biotech company that develops drugs for neurodegenerative and neuromuscular diseases. The company’s pipeline products comprise mitochondrial modulators such as MP-101, MP-201 and MP-301. It targets diseases such as batten disease, stroke, h …
  • GFI Informatique (GFI):企業の財務・戦略的SWOT分析
    GFI Informatique (GFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Olympic Mountain and Marine Products, Inc.:企業の戦略・SWOT・財務情報
    Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Olympic Mountain and Marine Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Internet Initiative Japan Inc (3774):企業の財務・戦略的SWOT分析
    Internet Initiative Japan Inc (3774) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆